Target type: biologicalprocess
The movement of an eosinophil in response to an external stimulus. [GOC:jid, PMID:11292027, PMID:12391252]
Eosinophil chemotaxis is a complex biological process that involves the directed migration of eosinophils, a type of white blood cell, towards a chemical stimulus. This process is crucial for the immune response, particularly in the context of allergic reactions and parasitic infections. Here's a breakdown of the key steps involved:
1. **Stimulus Release:** Eosinophil chemotaxis is initiated by the release of chemoattractants, chemical signals that attract eosinophils. These chemoattractants can be released by various cells, including mast cells, epithelial cells, and other immune cells. Some common eosinophil chemoattractants include:
- **Eosinophil chemotactic factor (ECF):** Released by mast cells and other immune cells, ECF is a potent attractant for eosinophils.
- **Leukotriene B4 (LTB4):** A lipid mediator produced by various cells, LTB4 is a strong chemoattractant for eosinophils.
- **Interleukin-5 (IL-5):** A cytokine produced by T lymphocytes and other cells, IL-5 plays a crucial role in eosinophil development and activation, indirectly contributing to chemotaxis.
2. **Eosinophil Activation:** Upon encountering chemoattractants, eosinophils become activated. This activation involves a cascade of intracellular signaling events that lead to changes in cell morphology and behavior.
3. **Chemotaxis Receptor Binding:** Eosinophils express specific receptors on their surface that recognize and bind to chemoattractants. These receptors, such as the chemokine receptor CCR3, initiate intracellular signaling pathways upon ligand binding.
4. **Signal Transduction:** The binding of chemoattractants to their receptors triggers a series of intracellular signaling events. These events involve second messenger molecules like cAMP and Ca2+, leading to activation of kinases and other signaling molecules.
5. **Actin Polymerization and Cell Polarization:** The signaling cascade results in the reorganization of the cytoskeleton, particularly the actin filaments. This reorganization leads to the formation of pseudopodia, finger-like projections that extend towards the source of the chemoattractant. The cell also polarizes, with the leading edge facing the chemoattractant and the trailing edge facing away.
6. **Directional Migration:** The formation of pseudopodia and cell polarization allows eosinophils to move directionally towards the chemoattractant. This movement involves a cycle of extension and retraction of pseudopodia, driven by the polymerization and depolymerization of actin filaments.
7. **Eosinophil Recruitment:** As eosinophils migrate towards the source of the chemoattractant, they accumulate at the site of inflammation or infection. This recruitment of eosinophils is essential for the immune response to allergic reactions and parasitic infections.
8. **Eosinophil Function:** Once at the site of action, eosinophils release a variety of cytotoxic and inflammatory mediators, such as:
- **Major basic protein (MBP):** A toxic protein that damages parasitic worms and other pathogens.
- **Eosinophil cationic protein (ECP):** A cytotoxic protein that kills parasites and contributes to tissue damage in allergic reactions.
- **Eosinophil peroxidase (EPO):** An enzyme that generates reactive oxygen species, which can be toxic to parasites and other pathogens.
The process of eosinophil chemotaxis is tightly regulated by a complex interplay of signaling molecules, receptors, and intracellular pathways. This intricate regulation ensures that eosinophils are recruited only when necessary and that their activation and effector functions are carefully controlled. This is crucial for maintaining immune homeostasis and preventing excessive inflammation and tissue damage.'
"
Protein | Definition | Taxonomy |
---|---|---|
C-C motif chemokine 2 | A C-C motif chemokine 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P13500] | Homo sapiens (human) |
Galectin-3 | A galectin-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17931] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
fasudil | fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia. fasudil: intracellular calcium antagonist; structure in first source | isoquinolines; N-sulfonyldiazepane | antihypertensive agent; calcium channel blocker; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; geroprotector; neuroprotective agent; nootropic agent; vasodilator agent |
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
galactose | alpha-D-galactoside : Any D-galactoside having alpha-configuration at its anomeric centre. | D-galactopyranose | mouse metabolite |
y 27632 | Y 27632: RN given for di-HCl salt; inhibits Rho-associated protein kinase; inhibits calcium sensitization to affect smooth muscle relaxation; structure in first source Y-27632 : A monocarboxylic acid amide that is trans-[(1R)-1-aminoethyl]cyclohexanecarboxamide in which one of the nitrogens of the aminocarbony group is substituted by a pyridine nucleus. It has been shown to exhibit inhibitory activity against Rho-associated protein kinase (ROCK) enzyme. | aromatic amide | |
galactal | galactal: RN given refers to cpd with unspecified isomeric designation; structure | anhydrohexose; glycal | |
ha 1100 | HA 1100: intracellular calcium antagonist | ||
incb3344 | INCB3344: potent and selective small molecule CCR2 chemokine receptor antagonist | ||
pf-2545920 |